LIGAND PHARMACEUTICALS INCORPORATED Payments to Acquire Assets, Investing Activities
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Payments to Acquire Assets, Investing Activities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAssetsInvestingActivities · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for the quarter ending 2025-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for the quarter ending 2025-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for the quarter ending 2024-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for the quarter ending 2024-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for fiscal 2024 was $75.00M.
- LIGAND PHARMACEUTICALS INCORPORATED payments to acquire assets, investing activities for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Assets, Investing Activities 3 month | Payments to Acquire Assets, Investing Activities 6 month | Payments to Acquire Assets, Investing Activities 9 month | Payments to Acquire Assets, Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $75.00M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $75.00M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $75.00M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |